{"gene":"MAP2K4","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1997,"finding":"MKK4 (JNKK1) functions as a direct activator of JNK in vivo; targeted disruption of MKK4 blocked JNK activation caused by MEKK1, anisomycin, and heat shock, and abolished regulated AP-1 transcriptional activity. MKK4 knockout mice die before embryonic day 14, and complementation with MKK4 expression vector restored AP-1 activity in KO cells.","method":"Gene knockout (targeted disruption), cell-based kinase assays, complementation transfection, AP-1 reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined phenotypic readout, complementation rescue, replicated by multiple downstream assays in one rigorous study","pmids":["9096336"],"is_preprint":false},{"year":1998,"finding":"JNKK1/MKK4 organizes a MAP kinase module by interacting with both MEKK1 (upstream) and JNK (downstream) through its amino-terminal extension. JNK and MEKK1 compete for binding to JNKK1, and activation of JNKK1 prevents its re-binding to MEKK1, indicating sequential MEKK1:JNKK1 and JNKK1:JNK interactions. Mutations in the N-terminal extension disrupt TNF-induced (but not stress-induced) JNK activation.","method":"Dominant-negative mutant analysis, co-immunoprecipitation, cell-based signaling assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, DN mutants, stimulus-specific dissection) in one focused study","pmids":["9808624"],"is_preprint":false},{"year":2000,"finding":"MKK4 shows a striking substrate preference for phosphorylation of the tyrosine residue (Tyr-185) in JNK1 isoforms, while MKK7 preferentially phosphorylates the threonine residue (Thr-183). Because both residues must be phosphorylated for full JNK activation, MKK4 and MKK7 act synergistically in vitro to maximally activate JNK. MKK4 also shows tyrosine-preference for p38 family substrates.","method":"In vitro kinase assay with phosphospecific site mutants, phosphoamino acid analysis of JNK1 isoforms","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro reconstitution with phosphosite mutagenesis, tested across multiple JNK isoforms","pmids":["11062067"],"is_preprint":false},{"year":1997,"finding":"MEKK2 and MEKK3 both phosphorylate and activate MKK4. The activating phosphorylation sites in MKK4 were mapped to Ser221 and Thr225 within kinase subdomains VII/VIII. Mutation of these residues abolished MKK4 activation by MEKK2 and MEKK3. Immunoprecipitated MEKK2 directly activated recombinant MKK4 in vitro but failed to activate MKK3.","method":"In vitro kinase assay, site-directed mutagenesis, cotransfection in COS-7 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis identifying exact phosphorylation sites","pmids":["9162092"],"is_preprint":false},{"year":1998,"finding":"MLK2 activates both MKK4 (SKK1) and MKK7 (SKK4) in transfection studies and in vitro, whereas MEKK1 activates MKK4 much more efficiently than MKK7 and barely activates MKK7. This differential activation suggests MEKK1 does not mediate cytokine (IL-1, TNF)-induced MKK7/JNK activation, while MLK2 can activate both arms.","method":"Cotransfection kinase assays, in vitro kinase assay with recombinant proteins","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution combined with cell-based assays, single lab","pmids":["9639556"],"is_preprint":false},{"year":1998,"finding":"The activated MEKK1→SEK1/MKK4 pathway induces COX-2 expression and PGE2 production, functioning as an upstream kinase capable of activating both p38 MAPK and JNK/SAPK. A constitutively active SEK1-ED increased p38 and JNK phosphorylation and PGE2/COX-2, while a dominant-negative SEK1-AL decreased these outputs.","method":"Overexpression of constitutively active and dominant-negative constructs, kinase activity assays, pharmacologic p38 inhibitor","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain/loss-of-function with defined molecular readouts, single lab, two orthogonal approaches","pmids":["9582321"],"is_preprint":false},{"year":1997,"finding":"SEK1/MKK4-deficient T cells show decreased proliferation and IL-2 production after CD28 costimulation and PMA/Ca2+ ionophore activation, establishing MKK4 as a required effector of CD28 signaling to IL-2 production. JNK activation in response to PMA/Ca2+ ionophore was absent in KO thymocytes but present in peripheral T cells, indicating developmentally regulated signaling.","method":"RAG2-/-chimeric mice with SEK1-/- cells, genetic KO, functional proliferation and cytokine assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO in primary cells with defined functional readouts, developmental context established","pmids":["9294148"],"is_preprint":false},{"year":2002,"finding":"MEKK1 phosphorylates and activates MKK4 (and MKK1), and MEKK1's own ubiquitylation (mediated by its PHD/E3 ligase domain, requiring kinase activity and Cys441) inhibits its ability to phosphorylate MKK4, thereby suppressing ERK1/2 and JNK activation. Mutation C441A prevents ubiquitylation and preserves MEKK1→MKK4 phosphorylation.","method":"In vitro kinase assay, ubiquitylation assay, site-directed mutagenesis (C441A PHD domain)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis, functional epistasis established","pmids":["12456688"],"is_preprint":false},{"year":2009,"finding":"MKK4/SEK1 undergoes ubiquitination and proteasomal degradation following cellular stress (sorbitol). The HECT-domain E3 ubiquitin ligase Itch binds MKK4, ubiquitinates lysines 140 and 143, and promotes MKK4 degradation through a JNK-dependent feedback loop (JNK kinase activity is required for MKK4 ubiquitination).","method":"Ubiquitination assays, co-immunoprecipitation, proteasome inhibitor treatment, site-directed mutagenesis of ubiquitin acceptor lysines","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical ubiquitination assay with site identification by mutagenesis, co-IP, and functional readout, single lab","pmids":["19737936"],"is_preprint":false},{"year":2011,"finding":"Nonvisual arrestins (arrestin-2 and arrestin-3) directly bind both MKK4 and JNK3α2 and act as scaffolds facilitating MKK4-mediated phosphorylation of JNK3α2. Reconstitution with purified proteins showed bell-shaped concentration dependence of JNK3α2 phosphorylation and JNK activity at low vs. high arrestin-3 concentration, consistent with true scaffold behavior. Arrestin-3 has higher affinity for both kinases than arrestin-2.","method":"In vitro reconstitution with purified proteins, direct binding assays, kinase activity assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution from purified components with functional readout and dose-response characterization","pmids":["22047447"],"is_preprint":false},{"year":2003,"finding":"In fibroblast-like synoviocytes from rheumatoid arthritis tissue, MKK4 and MKK7 co-immunoprecipitate with JNK, and MKK4 co-precipitates with MKK7, forming a stable ternary complex. This complex localizes to the cytoplasm by confocal microscopy, with JNK translocating to the nucleus after IL-1 stimulation. The complex phosphorylates c-Jun upon IL-1 stimulation.","method":"Co-immunoprecipitation, confocal microscopy, in vitro kinase assay of immunoprecipitated complex","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and functional activity from precipitated complex with localization data, single lab","pmids":["13130464"],"is_preprint":false},{"year":2009,"finding":"LRRK2 (Parkinson disease-associated kinase) phosphorylates MKK4 in vitro, exhibiting MAPKKK-like activity toward MKK4 and MKK7 as well as MKK3 and MKK6. The pathogenic G2019S and I2020T mutations show increased phosphotransferase activity toward MKK4.","method":"In vitro kinase assay with recombinant proteins, disease mutant comparison","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro kinase assay, single lab, no cellular validation of specific MKK4 site","pmids":["19302196"],"is_preprint":false},{"year":2012,"finding":"G2019S-LRRK2 phosphorylates MKK4 at Ser257 with augmented kinase activity in HEK293 cells, and phospho-MKK4(Ser257) is elevated in the substantia nigra of G2019S-LRRK2 transgenic mice. This leads to increased phospho-JNK and phospho-c-Jun, upregulated Bim and FasL, and caspase activation, identifying the LRRK2→MKK4→JNK→c-Jun pathway as a mediator of dopaminergic neuron degeneration.","method":"Cell-based kinase assay (HEK293 cells), phosphospecific Western blotting in transgenic mice, epistasis via pathway component measurement","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell and in vivo validation with phosphospecific antibodies, two orthogonal systems, single lab","pmids":["22539006"],"is_preprint":false},{"year":2010,"finding":"Filamin A (actin-binding protein 280) binds to both MKK4 and MKK7, connecting them in close proximity. Filamin family members A, B, and C interact with MKK4; the MKK7-binding region on Filamin A is distinct from its MKK4-binding region. Filamin-A-deficient cells show reduced MKK7 activation and impaired synergistic stress-induced JNK activation, establishing Filamin A as a scaffold linking the two MKK upstream kinases.","method":"Co-immunoprecipitation, Filamin-A-deficient cell lines, deletion mutant mapping, confocal co-localization, kinase assays","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, deletion mutant mapping, KO cells with functional readout, multiple orthogonal methods","pmids":["20156194"],"is_preprint":false},{"year":2009,"finding":"Cardiac-specific deletion of MKK4 in mice results in exacerbated pathological cardiac hypertrophy and cardiomyocyte apoptosis upon pressure overload or chronic beta-adrenergic stimulation, associated with upregulated NFAT transcriptional activity. Physiological hypertrophy induced by swimming exercise was unaffected. MKK4 expression was reduced in heart failure patients.","method":"Conditional cardiac KO (Cre-lox), pressure overload and pharmacologic stress models, NFAT reporter assay, histology","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with mechanistic readout (NFAT activation), multiple stress conditions, translational correlation","pmids":["19265040"],"is_preprint":false},{"year":2006,"finding":"MKK4 kinase activity is essential for metastasis suppression in ovarian cancer. Expression of MKK6 (a p38-specific activator) suppressed metastatic colonization similarly to MKK4, while MKK7 (JNK-specific) had no effect, placing the p38 pathway downstream of MKK4 as the key pathway for metastasis suppression.","method":"Kinase-inactive mutant expression, MKK6/MKK7 substitution, in vivo SCID mouse metastasis model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — kinase-dead mutant, pathway-specific substitution, in vivo readout, mechanistic epistasis established","pmids":["16489030"],"is_preprint":false},{"year":2005,"finding":"In prostate cancer, MKK4 and MKK7 kinase activities are active in the lung (secondary site) but not in the primary tumor, providing a biochemical basis for context-dependent metastasis suppression. MKK7 expression suppresses overt metastases (via JNK), whereas MKK6 had no effect in this model, indicating MKK4 suppresses prostate metastasis through JNK rather than p38.","method":"In vivo AT6.1 spontaneous metastasis model, MKK7/MKK6 expression constructs, phospho-specific Western blotting in primary vs. secondary site tissue","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo model with tissue-level biochemical analysis, pathway-specific kinase substitution, single lab","pmids":["16322247"],"is_preprint":false},{"year":2005,"finding":"POSH scaffold protein co-immunoprecipitates with MLK3, MKK4, and phospho-JNK in the rat hippocampus following cerebral ischemia; interactions are enhanced during reperfusion. Intracerebroventricular POSH antisense oligodeoxynucleotides reduced POSH protein, decreased its interaction with MKK4 and phospho-JNKs, attenuated MLK3-MKK4-JNK activation, and increased neuronal survival.","method":"Co-immunoprecipitation from brain tissue, antisense knockdown, immunohistochemistry, histology (neuronal density)","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP from native tissue with functional antisense KD and neuronal survival readout, single lab","pmids":["16248889"],"is_preprint":false},{"year":2009,"finding":"MKK4 (Ser80) is phosphorylated by the PI3K/Akt pathway in ovarian cells in response to EGF and TGF-β, and this inactivating phosphorylation is blocked 50-60% by the PI3K/Akt inhibitor wortmannin. The inactivated pSer80 form constitutes 62% of phosphorylated MKK4 in ovarian tumors, providing a mechanism for MKK4 functional inactivation without gene mutation.","method":"Western blotting with phosphospecific antibodies, pharmacologic inhibition (wortmannin), growth factor stimulation experiments","journal":"Gynecologic oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — phosphospecific antibody readout with pharmacologic inhibition, single lab, no direct kinase-substrate assay","pmids":["17276500"],"is_preprint":false},{"year":2011,"finding":"Map2k4 functions as a tumor suppressor in lung adenocarcinoma; conditional bronchial epithelial inactivation in Kras/Tp53-mutant mice accelerated lung neoplasia. MKK4 deficiency increased PPARγ2 expression through noncanonical substrates, and PPARγ2 enhanced tumor cell invasion. Eight of 11 cancer-associated MKK4 mutations reduced protein stability or impaired kinase activity.","method":"Conditional KO in Kras/Tp53 mouse model, biochemical characterization of cancer-associated mutants, PPARγ2 epistasis via knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo conditional KO, kinase activity of tumor-associated mutants, and mechanistic substrate identification via epistasis","pmids":["21896780"],"is_preprint":false},{"year":1999,"finding":"G-protein βγ subunit (Gβγ) activates MKK4 (6-fold) more potently than MKK7 (2-fold), and MKK4 activation by Gβγ is blocked by dominant-negative Rho, Cdc42, and specific tyrosine kinase inhibitors PP2/PP1, while MKK7 activation is blocked by dominant-negative Rac. This demonstrates that Gβγ preferentially signals to JNK through MKK4 via Rho/Cdc42 and tyrosine kinases.","method":"Cotransfection with dominant-negative Rho GTPases, pharmacologic kinase inhibitors, kinase assays in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with multiple dominant-negative constructs and pharmacologic inhibitors, single lab","pmids":["9890951"],"is_preprint":false},{"year":2009,"finding":"Delphinidin directly binds MAPKK4 (MKK4) and PI3K in an ATP-competitive manner, as demonstrated by pull-down with delphinidin-Sepharose beads, inhibiting their kinase activities and suppressing UVB-induced COX-2 expression in epidermal cells and mouse skin.","method":"Delphinidin-Sepharose pulldown assay (direct binding), in vitro kinase inhibition assay, in vivo mouse skin model","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct affinity pulldown with functional kinase inhibition readout, in vivo validation, single lab","pmids":["19776176"],"is_preprint":false},{"year":2011,"finding":"In ESC differentiation, MKK4 is required for p38 activation; Mkk4−/− ESCs display diminished phospho-ATF2 and MEF2C expression, resulting in impaired MHC induction and defective cardiomyocyte differentiation. Exogenous MKK4 expression partially restored cardiomyocyte differentiation. MKK7, by contrast, reduces p38 activation, and Mkk7−/− ESCs have elevated MKK4 and p38 phosphorylation and enhanced cardiomyocyte formation.","method":"Gene KO ESC lines, differentiation assays, phospho-specific Western blot, MKK4 rescue transfection","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary KO lines with rescue experiment, multiple downstream signaling readouts, functional differentiation phenotype","pmids":["22130668"],"is_preprint":false},{"year":2007,"finding":"PKC phosphorylation of JNK augments (but is not sufficient for) JNK activation by MKK4 or MKK7. In vitro kinase assays show that PKC phosphorylation of JNK must precede phosphorylation by MKK4/7 to enhance JNK activity. Inhibiting PKC phosphorylation of JNK affects both early and late phases of UV-induced JNK activation and reduces JNK-mediated apoptosis.","method":"In vitro kinase assay, sequential phosphorylation order experiments, pharmacologic PKC inhibition, apoptosis assay","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with order-of-addition experiment, single lab, limited cellular validation","pmids":["18182317"],"is_preprint":false},{"year":2006,"finding":"Different scaffold proteins differentially utilize MKK4 and MKK7 for JNK activation: LMP-1-induced JNK activation depends primarily on MKK4, Axin depends mainly on MKK7, and Dvl depends approximately equally on both. This was demonstrated using MKK4−/− and MKK4−/−/7−/− murine embryonic fibroblasts.","method":"Genetic KO MEFs (MKK4−/−, MKK4−/−/7−/−), scaffold protein overexpression, JNK activity assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with scaffold-specific epistasis, multiple scaffolds tested, single lab","pmids":["17187786"],"is_preprint":false},{"year":2009,"finding":"Knockdown of Sec8 enhances binding of JIP4 (JNK-interacting protein 4) to MKK4 and decreases the phosphorylation of MKK4, JNK, and p38, suggesting Sec8 regulates MKK4-JNK signaling by modulating JIP4-MKK4 scaffold interactions.","method":"Sec8 siRNA knockdown, co-immunoprecipitation (JIP4-MKK4 binding), phospho-specific Western blot","journal":"The FEBS journal","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP with indirect KD approach, single lab, no direct binding/kinase assay for MKK4","pmids":["25244576"],"is_preprint":false},{"year":2018,"finding":"MAP3K1 and MAP2K4 loss-of-function mutations confer sensitivity to MEK inhibition by disabling a JNK-JUN feedback loop that normally restores MAPK pathway activity upon MEK inhibition. MEK inhibition activates JNK-JUN signaling through suppression of DUSP4, and cancers lacking MAP2K4 fail to activate this feedback, disabling compensatory pathway re-activation.","method":"Loss-of-function mutation analysis in cancer cell lines and PDX models, DUSP4 modulation, JNK-JUN pathway measurements, 168-tumor PDX panel drug response","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in multiple cancer models and large PDX panel, mechanistic pathway dissection, single study","pmids":["29795445"],"is_preprint":false},{"year":2024,"finding":"First-in-class small molecule inhibitors of MKK4 (MKK4i) were developed via structure-based design (NMR spectroscopy characterization). MKK4i increased liver regeneration upon hepatectomy in murine and porcine models, allowed pig survival in an 85% hepatectomy model, and showed antisteatotic and antifibrotic effects in liver disease models. A phase I clinical trial with candidate HRX215 showed acceptable safety and pharmacokinetics.","method":"Structure-based drug design, NMR spectroscopy characterization, in vivo hepatectomy models (mouse, pig), liver disease mouse models, phase I clinical trial","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — structure-based development with NMR validation, multiple in vivo models including large animal, and first-in-human trial","pmids":["38490194"],"is_preprint":false},{"year":2020,"finding":"A dual covalent MKK4/7 inhibitor (BSJ-04-122) was developed that targets a conserved cysteine before the DFG motif in both kinases. It exhibits potent cellular target engagement, downstream JNK pathway inhibition, and enhanced antiproliferative activity in triple-negative breast cancer cells when combined with a JNK inhibitor.","method":"Covalent inhibitor design, proteomics-based target engagement (mass spectrometry), kinase selectivity profiling, cell viability assays","journal":"Cell chemical biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — covalent active-site targeting with MS validation and functional cellular readout, single lab","pmids":["32916088"],"is_preprint":false},{"year":2009,"finding":"In the Drosophila JNK pathway, Mkk4 plays a non-redundant role as a MAPKK acting in parallel to Hemipterous/Mkk7 in dTAK1-mediated JNK activation upon Eiger (TNF) and Imd pathway stimulation. Drosophila Mkk4 is dispensable for normal development but required (with Hep/Mkk7) for full JNK activation in the immune context.","method":"Dominant suppressor screen, allelic series genetic analysis, biochemical assays in Drosophila cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in Drosophila (ortholog system) with biochemical validation, multiple alleles","pmids":["19888449"],"is_preprint":false},{"year":2018,"finding":"In retinal ganglion cells, deficiency of Mkk4 or Mkk7 individually reduced JNK signaling after axonal injury (optic nerve crush) and each increased RGC survival. Combined deficiency of both Mkk4 and Mkk7 caused failure of optic nerve formation, irregular axonal trajectories, disrupted retinal lamination, and dendritic fasciculation, demonstrating redundant developmental roles and individual contributions to injury-induced apoptosis.","method":"Conditional retina-specific KO, optic nerve crush model, immunohistochemistry, RGC counting","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — single and double conditional KO with defined developmental and injury phenotypes, quantitative RGC survival data","pmids":["30367030"],"is_preprint":false},{"year":2007,"finding":"Targeted deletion of MKK4 abrogates TNF-induced NF-κB activation (IKK activation, IκBα phosphorylation/degradation, p65 nuclear translocation) and downregulates NF-κB-regulated anti-apoptotic gene products (survivin, IAP1, XIAP, Bcl-2, Bcl-xL, cFLIP), enhancing TNF-induced apoptosis in MKK4-KO fibroblasts.","method":"MKK4 gene-deleted fibroblasts from KO mice, NF-κB DNA binding assays, NF-κB reporter assay, Western blot for pathway components","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with multiple NF-κB pathway readouts and anti-apoptotic gene product measurements","pmids":["17641059"],"is_preprint":false},{"year":2019,"finding":"MAP2K4 interacts with Vimentin (co-immunoprecipitation) and activates the PI3K/AKT signaling pathway in breast cancer cells, promoting proliferation, migration, and invasion through downstream c-JUN activation, G1/S cell cycle progression, and EMT. MAP2K4 knockdown reversed these effects.","method":"Co-immunoprecipitation (MAP2K4-Vimentin), KD/OE in breast cancer cell lines, in vivo xenograft, phospho-PI3K/AKT Western blot","journal":"Aging","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single co-IP, single lab, no mechanistic dissection of direct phosphorylation between MAP2K4 and PI3K/AKT","pmids":["31761784"],"is_preprint":false}],"current_model":"MAP2K4 (MKK4/SEK1/JNKK1) is a dual-specificity MAPK kinase that preferentially phosphorylates the activating tyrosine (Tyr-185) of JNK and acts synergistically with MKK7 (which targets Thr-183) to fully activate JNK; it can also activate p38 MAPK. MKK4 is activated by upstream MAPKKKs including MEKK1, MEKK2, MEKK3, MLK2, ASK1, and LRRK2 (Parkinson-associated) through phosphorylation of Ser221/Thr225. Its specificity is conferred by an N-terminal extension that organizes sequential interactions within the MEKK1→MKK4→JNK module, and it is assembled into signalosomes by scaffold proteins (arrestin-3, POSH, Filamin A). MKK4 activity is negatively regulated by Itch-mediated ubiquitination at Lys140/143 (a JNK-dependent feedback) and by PI3K/Akt-driven phosphorylation at the inactivating Ser80 site. In vivo, MKK4 is essential for embryonic viability, regulates CD28-driven IL-2 production in T cells, NF-κB activation, cardiomyocyte stress responses (via NFAT signaling), retinal ganglion cell survival, and liver regeneration; small-molecule MKK4 inhibitors that enhance liver regeneration have entered phase I clinical trials."},"narrative":{"mechanistic_narrative":"MAP2K4 (MKK4/SEK1/JNKK1) is a dual-specificity MAP kinase kinase that operates at the core of stress-activated MAPK signaling, transducing diverse upstream inputs into JNK and p38 activation [PMID:9096336]. It directly activates JNK in vivo, and its loss blocks JNK activation by MEKK1, anisomycin, and heat shock, abolishes AP-1 transcriptional activity, and causes embryonic lethality [PMID:9096336]. MKK4 shows a striking substrate preference for the activating tyrosine (Tyr-185) of JNK, complementing MKK7's threonine specificity so that the two kinases act synergistically for full JNK activation; this tyrosine-directed preference extends to p38 family substrates [PMID:11062067]. Specificity within the cascade is achieved through MKK4's N-terminal extension, which organizes sequential MEKK1→MKK4→JNK interactions, with MEKK1 and JNK competing for binding [PMID:9808624]. MKK4 is activated by phosphorylation at Ser221/Thr225 by multiple MAPKKKs including MEKK2, MEKK3, MLK2, MEKK1, and the Parkinson-associated kinase LRRK2 [PMID:9162092, PMID:9639556, PMID:19302196]; the LRRK2→MKK4(Ser257)→JNK→c-Jun axis drives dopaminergic neuron degeneration [PMID:22539006]. Pathway assembly is governed by scaffold proteins—nonvisual arrestins bridge MKK4 and JNK3 [PMID:22047447], and Filamin A links MKK4 to MKK7 [PMID:20156194]—while MKK4 activity is negatively regulated by Itch-mediated ubiquitination at Lys140/143 in a JNK-dependent feedback loop [PMID:19737936] and by inactivating PI3K/Akt-driven phosphorylation at Ser80 [PMID:17276500]. Physiologically, MKK4 is required for CD28-driven IL-2 production in T cells [PMID:9294148], TNF-induced NF-κB activation and survival gene expression [PMID:17641059], cardiomyocyte stress responses through NFAT [PMID:19265040], retinal ganglion cell survival after injury [PMID:30367030], and acts as a tumor suppressor in lung and metastatic cancers [PMID:16489030, PMID:21896780]; structure-guided MKK4 inhibitors enhance liver regeneration and have entered phase I trials [PMID:38490194].","teleology":[{"year":1997,"claim":"Established MKK4 as a genuine in vivo activator of JNK rather than an in vitro curiosity, defining its essential role in stress-induced AP-1 signaling and development.","evidence":"Targeted gene disruption with complementation rescue and AP-1 reporter assays; KO mice lethal before E14","pmids":["9096336"],"confidence":"High","gaps":["Did not resolve relative contributions of JNK vs p38 downstream","Embryonic lethality limited adult tissue analysis"]},{"year":1997,"claim":"Identified the exact activating phosphorylation sites and multiple MAPKKK inputs, showing MKK4 integrates signals from several upstream kinases.","evidence":"In vitro kinase assays with Ser221/Thr225 mutagenesis, cotransfection of MEKK2/MEKK3 in COS-7 cells","pmids":["9162092"],"confidence":"High","gaps":["Did not establish which MAPKKK dominates in specific physiological stimuli","Specificity of MEKK2/3 vs MKK3 not fully mapped"]},{"year":1998,"claim":"Defined how MKK4 organizes a discrete kinase module, revealing sequential and competitive interactions that confer stimulus-specific signaling.","evidence":"Co-IP, dominant-negative mutants, and N-terminal extension mutagenesis dissecting TNF- vs stress-induced JNK activation","pmids":["9808624"],"confidence":"High","gaps":["Structural basis of competitive binding not solved","Stimulus specificity mechanism incompletely defined"]},{"year":1998,"claim":"Established differential MAPKKK preferences (MLK2 activates both MKK4 and MKK7; MEKK1 favors MKK4), explaining branch-specific upstream control of the JNK pathway.","evidence":"Cotransfection and in vitro kinase assays with recombinant proteins","pmids":["9639556"],"confidence":"High","gaps":["Did not map endogenous cytokine-specific MAPKKK usage","p38 branch contribution not addressed"]},{"year":2000,"claim":"Resolved the dual-residue logic of JNK activation, showing MKK4 preferentially phosphorylates Tyr-185 and acts synergistically with MKK7's Thr-183 targeting.","evidence":"In vitro kinase assays with phosphosite mutants and phosphoamino acid analysis across JNK isoforms","pmids":["11062067"],"confidence":"High","gaps":["In vitro preference may not reflect all cellular contexts","p38 phosphosite preference less quantified"]},{"year":1997,"claim":"Linked MKK4 to a defined immune output, demonstrating it is required for CD28-driven T cell IL-2 production and revealing developmentally regulated JNK signaling.","evidence":"RAG2-/- chimeras with SEK1-/- cells, proliferation and cytokine assays","pmids":["9294148"],"confidence":"High","gaps":["Mechanism of developmental difference between thymocytes and peripheral T cells unresolved"]},{"year":1998,"claim":"Connected MKK4 to inflammatory gene output by placing the MEKK1→SEK1 pathway upstream of both p38 and JNK driving COX-2/PGE2.","evidence":"Constitutively active and dominant-negative SEK1 constructs with kinase and prostaglandin readouts","pmids":["9582321"],"confidence":"Medium","gaps":["Overexpression-based; endogenous contribution not measured","Direct vs indirect COX-2 induction not separated"]},{"year":1999,"claim":"Defined an upstream GPCR-linked route, showing Gβγ preferentially signals to JNK through MKK4 via Rho/Cdc42 and tyrosine kinases.","evidence":"Cotransfection with dominant-negative Rho GTPases and pharmacologic inhibitors in HEK293","pmids":["9890951"],"confidence":"Medium","gaps":["Intermediate MAPKKK not identified","Pharmacologic inhibitor specificity caveats"]},{"year":2002,"claim":"Revealed an upstream negative-feedback layer where MEKK1 autoubiquitylation limits its own ability to phosphorylate MKK4.","evidence":"In vitro kinase and ubiquitylation assays with PHD domain C441A mutant","pmids":["12456688"],"confidence":"High","gaps":["Cellular relevance and kinetics of feedback not fully quantified"]},{"year":2003,"claim":"Demonstrated MKK4, MKK7, and JNK form a stable cytoplasmic ternary complex in disease tissue that phosphorylates c-Jun upon IL-1 stimulation.","evidence":"Reciprocal co-IP, confocal microscopy, and in vitro kinase assays in rheumatoid synoviocytes","pmids":["13130464"],"confidence":"Medium","gaps":["Scaffold organizing the complex not identified here","Stoichiometry undefined"]},{"year":2005,"claim":"Showed MKK4 suppresses metastasis in a context-dependent manner, acting through JNK in prostate cancer with site-specific kinase activation.","evidence":"In vivo AT6.1 metastasis model with MKK6/MKK7 substitution and phospho-Western in primary vs secondary tissue","pmids":["16322247"],"confidence":"Medium","gaps":["Mechanism of site-restricted activation unknown","Contrasts with p38-dependent suppression in ovarian cancer"]},{"year":2006,"claim":"Established that the downstream pathway mediating MKK4 metastasis suppression is tissue-dependent (p38 in ovarian cancer), using pathway-specific kinase substitution.","evidence":"Kinase-inactive MKK4 and MKK6/MKK7 substitution in SCID mouse ovarian metastasis model","pmids":["16489030"],"confidence":"High","gaps":["Determinants of p38 vs JNK pathway choice unresolved"]},{"year":2006,"claim":"Demonstrated scaffold proteins differentially channel signals through MKK4 vs MKK7, defining branch selection at the scaffold level.","evidence":"JNK activity assays in MKK4-/- and MKK4-/-/7-/- MEFs with LMP-1, Axin, and Dvl","pmids":["17187786"],"confidence":"Medium","gaps":["Structural basis of scaffold-MKK preference not defined"]},{"year":2007,"claim":"Connected MKK4 to canonical NF-κB survival signaling, showing its loss abrogates TNF-induced NF-κB activation and sensitizes cells to apoptosis.","evidence":"MKK4-deleted fibroblasts with NF-κB DNA binding, reporter, and anti-apoptotic gene readouts","pmids":["17641059"],"confidence":"High","gaps":["Direct molecular link between MKK4 and IKK not established","Crosstalk with JNK arm not dissected"]},{"year":2007,"claim":"Revealed a priming layer where PKC phosphorylation of JNK must precede MKK4/7 action to augment JNK activity.","evidence":"In vitro sequential phosphorylation assays with PKC inhibition and apoptosis readout","pmids":["18182317"],"confidence":"Medium","gaps":["Cellular validation limited","PKC isoform and JNK site not specified"]},{"year":2009,"claim":"Identified Itch-mediated ubiquitination at Lys140/143 as a JNK-dependent negative feedback controlling MKK4 stability.","evidence":"Ubiquitination assays, co-IP, proteasome inhibition, and acceptor-lysine mutagenesis after sorbitol stress","pmids":["19737936"],"confidence":"High","gaps":["Physiological stimuli triggering this feedback beyond sorbitol unclear"]},{"year":2009,"claim":"Defined an inactivating phosphorylation mechanism (Ser80 via PI3K/Akt) that silences MKK4 in tumors without gene mutation.","evidence":"Phosphospecific Western blotting with wortmannin and growth factor stimulation in ovarian cells","pmids":["17276500"],"confidence":"Medium","gaps":["Direct kinase-substrate relationship not demonstrated","Identity of the Ser80 kinase not confirmed"]},{"year":2009,"claim":"Connected MKK4 to neurodegeneration by identifying LRRK2 as a MAPKKK acting on MKK4, with pathogenic mutants showing enhanced activity.","evidence":"In vitro kinase assays with recombinant LRRK2 and G2019S/I2020T mutant comparison","pmids":["19302196"],"confidence":"Medium","gaps":["No cellular validation of the specific MKK4 site in this study","Selectivity among MKKs not resolved"]},{"year":2009,"claim":"Established a scaffold-based assembly of the MLK3-MKK4-JNK module in ischemic neurons, with POSH disruption promoting survival.","evidence":"Co-IP from rat hippocampus and antisense knockdown after cerebral ischemia","pmids":["16248889"],"confidence":"Medium","gaps":["Direct MKK4-POSH binding interface not mapped"]},{"year":2009,"claim":"Defined a cardioprotective role: cardiac MKK4 deletion exacerbates pathological hypertrophy and apoptosis via elevated NFAT activity.","evidence":"Conditional cardiac KO under pressure overload and beta-adrenergic stress with NFAT reporter and patient correlation","pmids":["19265040"],"confidence":"High","gaps":["Mechanistic link between MKK4 and NFAT suppression not fully defined"]},{"year":2010,"claim":"Identified Filamin A as a scaffold physically linking MKK4 and MKK7 to enable their synergistic stress-induced JNK activation.","evidence":"Reciprocal co-IP, deletion mapping, Filamin-A-deficient cells, and kinase assays","pmids":["20156194"],"confidence":"High","gaps":["Whether Filamin A also organizes JNK in the complex not shown"]},{"year":2011,"claim":"Reconstituted arrestin-3 as a bona fide scaffold for MKK4-mediated JNK3 phosphorylation, demonstrating classic scaffold concentration dependence.","evidence":"In vitro reconstitution from purified proteins with binding and dose-response kinase assays","pmids":["22047447"],"confidence":"High","gaps":["In vivo relevance of arrestin scaffolding for MKK4 not established"]},{"year":2011,"claim":"Established MKK4 as a lung adenocarcinoma tumor suppressor acting through noncanonical substrates (PPARγ2), with cancer mutations impairing stability or kinase activity.","evidence":"Conditional KO in Kras/Tp53 mice, biochemical mutant characterization, and PPARγ2 epistasis","pmids":["21896780"],"confidence":"High","gaps":["Direct MKK4 substrate driving PPARγ2 regulation not identified"]},{"year":2011,"claim":"Showed MKK4 is required for p38 activation during cardiomyocyte differentiation, with MKK4 and MKK7 exerting opposing effects on p38 output.","evidence":"Mkk4-/- and Mkk7-/- ESC differentiation assays with phospho-ATF2/MEF2C readouts and MKK4 rescue","pmids":["22130668"],"confidence":"High","gaps":["Mechanism by which MKK7 antagonizes p38 not resolved"]},{"year":2012,"claim":"Validated the LRRK2→MKK4(Ser257)→JNK→c-Jun axis as a driver of dopaminergic neuron degeneration in cells and transgenic mice.","evidence":"Cell-based kinase assays in HEK293, phosphospecific Western in G2019S-LRRK2 transgenic substantia nigra, pathway component measurement","pmids":["22539006"],"confidence":"Medium","gaps":["Causal requirement of MKK4 for neurodegeneration not tested by MKK4 deletion"]},{"year":2018,"claim":"Revealed MKK4 deficiency as a determinant of MEK inhibitor sensitivity by disabling a JNK-JUN feedback loop that normally restores MAPK activity.","evidence":"Loss-of-function analysis in cancer cell lines and a 168-tumor PDX panel with DUSP4 modulation","pmids":["29795445"],"confidence":"Medium","gaps":["Direct MKK4 substrates in the feedback loop not enumerated"]},{"year":2018,"claim":"Demonstrated individual and redundant roles of MKK4 and MKK7 in retinal ganglion cell survival and development through single and double KO.","evidence":"Conditional retina-specific KO with optic nerve crush and quantitative RGC survival counts","pmids":["30367030"],"confidence":"High","gaps":["Molecular basis of developmental redundancy not dissected"]},{"year":2020,"claim":"Delivered a covalent MKK4/7 inhibitor targeting a conserved pre-DFG cysteine, enabling combinatorial pathway suppression in cancer cells.","evidence":"Covalent inhibitor design with MS-based target engagement and TNBC cell viability assays","pmids":["32916088"],"confidence":"Medium","gaps":["Dual MKK4/7 inhibition complicates attribution to MKK4 alone","In vivo efficacy not established here"]},{"year":2024,"claim":"Translated MKK4 inhibition into a regenerative therapy, with structure-based MKK4 inhibitors enhancing liver regeneration and entering first-in-human testing.","evidence":"Structure-based design with NMR, mouse and pig hepatectomy models, liver disease models, and phase I trial of HRX215","pmids":["38490194"],"confidence":"High","gaps":["Long-term safety and efficacy from larger trials pending","Tumor-suppressor role raises theoretical oncogenic risk not resolved here"]},{"year":null,"claim":"How MKK4 selects between JNK and p38 outputs in different tissues, and how its substrate choice is reconciled with its dual tumor-suppressor and pro-survival roles, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model for tissue-specific JNK vs p38 channeling","Noncanonical substrates largely uncharacterized","Reconciliation of tumor suppression with regenerative inhibitor strategy incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,3,9]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,9,13]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12,30,31]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[15,19,26]}],"complexes":["MKK4-MKK7-JNK ternary complex"],"partners":["MAP3K1","MAP2K7","MAPK8","ARRB2","ARRB1","FLNA","ITCH","LRRK2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P45985","full_name":"Dual specificity mitogen-activated protein kinase kinase 4","aliases":["JNK-activating kinase 1","MAPK/ERK kinase 4","MEK 4","SAPK/ERK kinase 1","SEK1","Stress-activated protein kinase kinase 1","SAPK kinase 1","SAPKK-1","SAPKK1","c-Jun N-terminal kinase kinase 1","JNKK"],"length_aa":399,"mass_kda":44.3,"function":"Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Essential component of the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. With MAP2K7/MKK7, is the one of the only known kinase to directly activate the stress-activated protein kinase/c-Jun N-terminal kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3. MAP2K4/MKK4 and MAP2K7/MKK7 both activate the JNKs by phosphorylation, but they differ in their preference for the phosphorylation site in the Thr-Pro-Tyr motif. MAP2K4 shows preference for phosphorylation of the Tyr residue and MAP2K7/MKK7 for the Thr residue. The phosphorylation of the Thr residue by MAP2K7/MKK7 seems to be the prerequisite for JNK activation at least in response to pro-inflammatory cytokines, while other stimuli activate both MAP2K4/MKK4 and MAP2K7/MKK7 which synergistically phosphorylate JNKs. MAP2K4 is required for maintaining peripheral lymphoid homeostasis. The MKK/JNK signaling pathway is also involved in mitochondrial death signaling pathway, including the release cytochrome c, leading to apoptosis. Whereas MAP2K7/MKK7 exclusively activates JNKs, MAP2K4/MKK4 additionally activates the p38 MAPKs MAPK11, MAPK12, MAPK13 and MAPK14","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P45985/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAP2K4","classification":"Not Classified","n_dependent_lines":16,"n_total_lines":1208,"dependency_fraction":0.013245033112582781},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MAPK8","stoichiometry":0.2},{"gene":"MAPK9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MAP2K4","total_profiled":1310},"omim":[{"mim_id":"618642","title":"SH3 DOMAIN-CONTAINING RING FINGER PROTEIN 1; SH3RF1","url":"https://www.omim.org/entry/618642"},{"mim_id":"613416","title":"SCINDERIN; SCIN","url":"https://www.omim.org/entry/613416"},{"mim_id":"613347","title":"PANCREATIC CANCER, SUSCEPTIBILITY TO, 2","url":"https://www.omim.org/entry/613347"},{"mim_id":"613199","title":"TAO KINASE 2; TAOK2","url":"https://www.omim.org/entry/613199"},{"mim_id":"611931","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1L; PPM1L","url":"https://www.omim.org/entry/611931"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MAP2K4"},"hgnc":{"alias_symbol":["MEK4","JNKK1","PRKMK4","MKK4","MAPKK4","SAPKK1","SKK1","JNKK","SEK1"],"prev_symbol":["SERK1"]},"alphafold":{"accession":"P45985","domains":[{"cath_id":"3.30.200.20","chopping":"81-177","consensus_level":"high","plddt":85.9061,"start":81,"end":177},{"cath_id":"1.10.510.10","chopping":"183-385","consensus_level":"high","plddt":91.4213,"start":183,"end":385}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P45985","model_url":"https://alphafold.ebi.ac.uk/files/AF-P45985-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P45985-F1-predicted_aligned_error_v6.png","plddt_mean":77.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAP2K4","jax_strain_url":"https://www.jax.org/strain/search?query=MAP2K4"},"sequence":{"accession":"P45985","fasta_url":"https://rest.uniprot.org/uniprotkb/P45985.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P45985/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P45985"}},"corpus_meta":[{"pmid":"7634327","id":"PMC_7634327","title":"Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7634327","citation_count":674,"is_preprint":false},{"pmid":"12097290","id":"PMC_12097290","title":"Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12097290","citation_count":337,"is_preprint":false},{"pmid":"7522971","id":"PMC_7522971","title":"Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7522971","citation_count":326,"is_preprint":false},{"pmid":"9096336","id":"PMC_9096336","title":"Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9096336","citation_count":247,"is_preprint":false},{"pmid":"9582321","id":"PMC_9582321","title":"Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9582321","citation_count":226,"is_preprint":false},{"pmid":"10936203","id":"PMC_10936203","title":"MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo.","date":"2000","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10936203","citation_count":204,"is_preprint":false},{"pmid":"9808624","id":"PMC_9808624","title":"JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9808624","citation_count":175,"is_preprint":false},{"pmid":"11062067","id":"PMC_11062067","title":"Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11062067","citation_count":164,"is_preprint":false},{"pmid":"9622070","id":"PMC_9622070","title":"Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9622070","citation_count":150,"is_preprint":false},{"pmid":"19302196","id":"PMC_19302196","title":"The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19302196","citation_count":149,"is_preprint":false},{"pmid":"17157936","id":"PMC_17157936","title":"Physiological roles of MKK4 and MKK7: insights from animal models.","date":"2006","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17157936","citation_count":146,"is_preprint":false},{"pmid":"22539006","id":"PMC_22539006","title":"(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22539006","citation_count":145,"is_preprint":false},{"pmid":"24830651","id":"PMC_24830651","title":"EDR1 physically interacts with MKK4/MKK5 and negatively regulates a MAP kinase cascade to modulate plant innate immunity.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24830651","citation_count":132,"is_preprint":false},{"pmid":"12438272","id":"PMC_12438272","title":"Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12438272","citation_count":122,"is_preprint":false},{"pmid":"15670787","id":"PMC_15670787","title":"Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15670787","citation_count":120,"is_preprint":false},{"pmid":"21333379","id":"PMC_21333379","title":"The bottleneck of JNK signaling: molecular and functional characteristics of MKK4 and MKK7.","date":"2011","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21333379","citation_count":114,"is_preprint":false},{"pmid":"23355465","id":"PMC_23355465","title":"MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23355465","citation_count":113,"is_preprint":false},{"pmid":"16489030","id":"PMC_16489030","title":"The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16489030","citation_count":105,"is_preprint":false},{"pmid":"9294148","id":"PMC_9294148","title":"Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9294148","citation_count":105,"is_preprint":false},{"pmid":"9162092","id":"PMC_9162092","title":"Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9162092","citation_count":105,"is_preprint":false},{"pmid":"29795445","id":"PMC_29795445","title":"MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.","date":"2018","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29795445","citation_count":98,"is_preprint":false},{"pmid":"10785355","id":"PMC_10785355","title":"Mitogen-activated protein kinase kinase 4 (MKK4).","date":"2000","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10785355","citation_count":95,"is_preprint":false},{"pmid":"15184866","id":"PMC_15184866","title":"Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15184866","citation_count":92,"is_preprint":false},{"pmid":"19638505","id":"PMC_19638505","title":"MEK4 function, genistein treatment, and invasion of human prostate cancer cells.","date":"2009","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/19638505","citation_count":91,"is_preprint":false},{"pmid":"10187804","id":"PMC_10187804","title":"The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10187804","citation_count":88,"is_preprint":false},{"pmid":"19351724","id":"PMC_19351724","title":"Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity.","date":"2009","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19351724","citation_count":88,"is_preprint":false},{"pmid":"24556602","id":"PMC_24556602","title":"MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.","date":"2014","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24556602","citation_count":81,"is_preprint":false},{"pmid":"12456688","id":"PMC_12456688","title":"Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12456688","citation_count":78,"is_preprint":false},{"pmid":"31594754","id":"PMC_31594754","title":"Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.","date":"2019","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/31594754","citation_count":77,"is_preprint":false},{"pmid":"8812059","id":"PMC_8812059","title":"Expression of the Tyro4/Mek4/Cek4 gene specifically marks a subset of embryonic motor neurons and their muscle targets.","date":"1996","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/8812059","citation_count":76,"is_preprint":false},{"pmid":"19776176","id":"PMC_19776176","title":"Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase.","date":"2009","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/19776176","citation_count":75,"is_preprint":false},{"pmid":"24466137","id":"PMC_24466137","title":"Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24466137","citation_count":74,"is_preprint":false},{"pmid":"16322247","id":"PMC_16322247","title":"Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16322247","citation_count":72,"is_preprint":false},{"pmid":"9714150","id":"PMC_9714150","title":"Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.","date":"1998","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9714150","citation_count":72,"is_preprint":false},{"pmid":"9379049","id":"PMC_9379049","title":"Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9379049","citation_count":72,"is_preprint":false},{"pmid":"24532253","id":"PMC_24532253","title":"LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4.","date":"2014","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24532253","citation_count":69,"is_preprint":false},{"pmid":"21549720","id":"PMC_21549720","title":"Myricetin attenuated MPP(+)-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells.","date":"2011","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21549720","citation_count":67,"is_preprint":false},{"pmid":"32016794","id":"PMC_32016794","title":"Astrocyte-Derived Exosomal microRNA miR-200a-3p Prevents MPP+-Induced Apoptotic Cell Death Through Down-Regulation of MKK4.","date":"2020","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/32016794","citation_count":66,"is_preprint":false},{"pmid":"19265040","id":"PMC_19265040","title":"Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19265040","citation_count":66,"is_preprint":false},{"pmid":"23995397","id":"PMC_23995397","title":"Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.","date":"2013","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/23995397","citation_count":62,"is_preprint":false},{"pmid":"15623633","id":"PMC_15623633","title":"MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.","date":"2004","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/15623633","citation_count":59,"is_preprint":false},{"pmid":"21896780","id":"PMC_21896780","title":"Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21896780","citation_count":59,"is_preprint":false},{"pmid":"9639556","id":"PMC_9639556","title":"Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9639556","citation_count":55,"is_preprint":false},{"pmid":"27594411","id":"PMC_27594411","title":"Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27594411","citation_count":54,"is_preprint":false},{"pmid":"23034448","id":"PMC_23034448","title":"TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7.","date":"2012","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/23034448","citation_count":54,"is_preprint":false},{"pmid":"13130464","id":"PMC_13130464","title":"Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.","date":"2003","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/13130464","citation_count":54,"is_preprint":false},{"pmid":"9890951","id":"PMC_9890951","title":"Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9890951","citation_count":53,"is_preprint":false},{"pmid":"19888449","id":"PMC_19888449","title":"A non-redundant role for Drosophila Mkk4 and hemipterous/Mkk7 in TAK1-mediated activation of JNK.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19888449","citation_count":51,"is_preprint":false},{"pmid":"24705900","id":"PMC_24705900","title":"miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathway.","date":"2014","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/24705900","citation_count":50,"is_preprint":false},{"pmid":"22047447","id":"PMC_22047447","title":"Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22047447","citation_count":50,"is_preprint":false},{"pmid":"16627982","id":"PMC_16627982","title":"Homozygous deletion of MKK4 in ovarian serous carcinoma.","date":"2006","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/16627982","citation_count":49,"is_preprint":false},{"pmid":"12034736","id":"PMC_12034736","title":"Bisindolylmaleimide VIII enhances DR5-mediated apoptosis through the MKK4/JNK/p38 kinase and the mitochondrial pathways.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12034736","citation_count":49,"is_preprint":false},{"pmid":"38490194","id":"PMC_38490194","title":"First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/38490194","citation_count":48,"is_preprint":false},{"pmid":"31710596","id":"PMC_31710596","title":"MicroRNA-27a-3p Downregulation Inhibits Inflammatory Response and Hippocampal Neuronal Cell Apoptosis by Upregulating Mitogen-Activated Protein Kinase 4 (MAP2K4) Expression in Epilepsy: In Vivo and In Vitro Studies.","date":"2019","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/31710596","citation_count":47,"is_preprint":false},{"pmid":"28454307","id":"PMC_28454307","title":"miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28454307","citation_count":46,"is_preprint":false},{"pmid":"11754110","id":"PMC_11754110","title":"Mutation rate of MAP2K4/MKK4 in breast carcinoma.","date":"2002","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11754110","citation_count":45,"is_preprint":false},{"pmid":"30366472","id":"PMC_30366472","title":"Intronic miR-744 Inhibits Glioblastoma Migration by Functionally Antagonizing Its Host Gene MAP2K4.","date":"2018","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30366472","citation_count":45,"is_preprint":false},{"pmid":"19998410","id":"PMC_19998410","title":"PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.","date":"2010","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19998410","citation_count":45,"is_preprint":false},{"pmid":"12054537","id":"PMC_12054537","title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12054537","citation_count":44,"is_preprint":false},{"pmid":"17379190","id":"PMC_17379190","title":"Inhibition of lipopolysaccharide-stimulated NO production by a novel synthetic compound CYL-4d in RAW 264.7 macrophages involving the blockade of MEK4/JNK/AP-1 pathway.","date":"2007","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17379190","citation_count":44,"is_preprint":false},{"pmid":"31761784","id":"PMC_31761784","title":"MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31761784","citation_count":42,"is_preprint":false},{"pmid":"33494806","id":"PMC_33494806","title":"LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33494806","citation_count":42,"is_preprint":false},{"pmid":"20096264","id":"PMC_20096264","title":"Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1.","date":"2010","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20096264","citation_count":41,"is_preprint":false},{"pmid":"25019290","id":"PMC_25019290","title":"Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25019290","citation_count":40,"is_preprint":false},{"pmid":"16248889","id":"PMC_16248889","title":"Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16248889","citation_count":39,"is_preprint":false},{"pmid":"28319306","id":"PMC_28319306","title":"MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.","date":"2017","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/28319306","citation_count":38,"is_preprint":false},{"pmid":"11024538","id":"PMC_11024538","title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages.","date":"2000","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/11024538","citation_count":37,"is_preprint":false},{"pmid":"26589455","id":"PMC_26589455","title":"Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.","date":"2015","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26589455","citation_count":35,"is_preprint":false},{"pmid":"28655615","id":"PMC_28655615","title":"lncRNA-Map2k4 sequesters miR-199a to promote FGF1 expression and spinal cord neuron growth.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28655615","citation_count":34,"is_preprint":false},{"pmid":"20801953","id":"PMC_20801953","title":"Diverse physiological functions of MKK4 and MKK7 during early embryogenesis.","date":"2010","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20801953","citation_count":34,"is_preprint":false},{"pmid":"32059638","id":"PMC_32059638","title":"Tanshinone IIA prevents platelet activation and down-regulates CD36 and MKK4/JNK2 signaling pathway.","date":"2020","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32059638","citation_count":31,"is_preprint":false},{"pmid":"17559804","id":"PMC_17559804","title":"Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17559804","citation_count":31,"is_preprint":false},{"pmid":"12650604","id":"PMC_12650604","title":"MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.","date":"2003","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/12650604","citation_count":29,"is_preprint":false},{"pmid":"30878547","id":"PMC_30878547","title":"Paeoniflorin inhibits tributyltin chloride-induced apoptosis in hypothalamic neurons via inhibition of MKK4-JNK signaling pathway.","date":"2019","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30878547","citation_count":29,"is_preprint":false},{"pmid":"36536076","id":"PMC_36536076","title":"Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway.","date":"2022","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/36536076","citation_count":28,"is_preprint":false},{"pmid":"33061432","id":"PMC_33061432","title":"Saikosaponin D Inhibits Proliferation and Promotes Apoptosis Through Activation of MKK4-JNK Signaling Pathway in Pancreatic Cancer Cells.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33061432","citation_count":28,"is_preprint":false},{"pmid":"36099654","id":"PMC_36099654","title":"Study on the mechanism of Tong-Qiao-Huo-Xue decoction regulating apoptosis via ASK1/MKK4/JNK pathway in MCAO/R rats.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36099654","citation_count":28,"is_preprint":false},{"pmid":"15122334","id":"PMC_15122334","title":"Disruption of MKK4 signaling reveals its tumor-suppressor role in embryonic stem cells.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15122334","citation_count":28,"is_preprint":false},{"pmid":"19012245","id":"PMC_19012245","title":"Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes.","date":"2009","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/19012245","citation_count":27,"is_preprint":false},{"pmid":"20156194","id":"PMC_20156194","title":"Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20156194","citation_count":27,"is_preprint":false},{"pmid":"18182317","id":"PMC_18182317","title":"Requirements for PKC-augmented JNK activation by MKK4/7.","date":"2007","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18182317","citation_count":27,"is_preprint":false},{"pmid":"30367030","id":"PMC_30367030","title":"Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30367030","citation_count":26,"is_preprint":false},{"pmid":"35265821","id":"PMC_35265821","title":"The ARM repeat domain of hemocyanin interacts with MKK4 to modulate antimicrobial peptides expression.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35265821","citation_count":26,"is_preprint":false},{"pmid":"28939483","id":"PMC_28939483","title":"MKK4 from Litopenaeus vannamei is a regulator of p38 MAPK kinase and involved in anti-bacterial response.","date":"2017","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28939483","citation_count":25,"is_preprint":false},{"pmid":"31369289","id":"PMC_31369289","title":"Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.","date":"2019","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31369289","citation_count":25,"is_preprint":false},{"pmid":"32916088","id":"PMC_32916088","title":"Discovery of Covalent MKK4/7 Dual Inhibitor.","date":"2020","source":"Cell chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32916088","citation_count":23,"is_preprint":false},{"pmid":"22031940","id":"PMC_22031940","title":"A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization.","date":"2011","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/22031940","citation_count":23,"is_preprint":false},{"pmid":"24104352","id":"PMC_24104352","title":"Isoangustone A, a novel licorice compound, inhibits cell proliferation by targeting PI3K, MKK4, and MKK7 in human melanoma.","date":"2013","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/24104352","citation_count":23,"is_preprint":false},{"pmid":"17276500","id":"PMC_17276500","title":"Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.","date":"2007","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17276500","citation_count":22,"is_preprint":false},{"pmid":"37224750","id":"PMC_37224750","title":"Fluorofenidone protects against acute liver failure in mice by regulating MKK4/JNK pathway.","date":"2023","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/37224750","citation_count":21,"is_preprint":false},{"pmid":"22130668","id":"PMC_22130668","title":"Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22130668","citation_count":21,"is_preprint":false},{"pmid":"17641059","id":"PMC_17641059","title":"Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the down-regulation of NF-kappa B activation and NF-kappa B-regulated antiapoptotic gene products.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17641059","citation_count":21,"is_preprint":false},{"pmid":"37108658","id":"PMC_37108658","title":"MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108658","citation_count":20,"is_preprint":false},{"pmid":"18572308","id":"PMC_18572308","title":"New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.","date":"2008","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/18572308","citation_count":20,"is_preprint":false},{"pmid":"32779194","id":"PMC_32779194","title":"Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32779194","citation_count":20,"is_preprint":false},{"pmid":"21575258","id":"PMC_21575258","title":"Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21575258","citation_count":20,"is_preprint":false},{"pmid":"25244576","id":"PMC_25244576","title":"Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25244576","citation_count":20,"is_preprint":false},{"pmid":"17187786","id":"PMC_17187786","title":"Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17187786","citation_count":20,"is_preprint":false},{"pmid":"19737936","id":"PMC_19737936","title":"MKK4/SEK1 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase itch.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19737936","citation_count":20,"is_preprint":false},{"pmid":"30187994","id":"PMC_30187994","title":"Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression.","date":"2018","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/30187994","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54193,"output_tokens":8716,"usd":0.146659,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18329,"output_tokens":7216,"usd":0.136022,"stage2_stop_reason":"end_turn"},"total_usd":0.282681,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"MKK4 (JNKK1) functions as a direct activator of JNK in vivo; targeted disruption of MKK4 blocked JNK activation caused by MEKK1, anisomycin, and heat shock, and abolished regulated AP-1 transcriptional activity. MKK4 knockout mice die before embryonic day 14, and complementation with MKK4 expression vector restored AP-1 activity in KO cells.\",\n      \"method\": \"Gene knockout (targeted disruption), cell-based kinase assays, complementation transfection, AP-1 reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined phenotypic readout, complementation rescue, replicated by multiple downstream assays in one rigorous study\",\n      \"pmids\": [\"9096336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"JNKK1/MKK4 organizes a MAP kinase module by interacting with both MEKK1 (upstream) and JNK (downstream) through its amino-terminal extension. JNK and MEKK1 compete for binding to JNKK1, and activation of JNKK1 prevents its re-binding to MEKK1, indicating sequential MEKK1:JNKK1 and JNKK1:JNK interactions. Mutations in the N-terminal extension disrupt TNF-induced (but not stress-induced) JNK activation.\",\n      \"method\": \"Dominant-negative mutant analysis, co-immunoprecipitation, cell-based signaling assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, DN mutants, stimulus-specific dissection) in one focused study\",\n      \"pmids\": [\"9808624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MKK4 shows a striking substrate preference for phosphorylation of the tyrosine residue (Tyr-185) in JNK1 isoforms, while MKK7 preferentially phosphorylates the threonine residue (Thr-183). Because both residues must be phosphorylated for full JNK activation, MKK4 and MKK7 act synergistically in vitro to maximally activate JNK. MKK4 also shows tyrosine-preference for p38 family substrates.\",\n      \"method\": \"In vitro kinase assay with phosphospecific site mutants, phosphoamino acid analysis of JNK1 isoforms\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro reconstitution with phosphosite mutagenesis, tested across multiple JNK isoforms\",\n      \"pmids\": [\"11062067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"MEKK2 and MEKK3 both phosphorylate and activate MKK4. The activating phosphorylation sites in MKK4 were mapped to Ser221 and Thr225 within kinase subdomains VII/VIII. Mutation of these residues abolished MKK4 activation by MEKK2 and MEKK3. Immunoprecipitated MEKK2 directly activated recombinant MKK4 in vitro but failed to activate MKK3.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, cotransfection in COS-7 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis identifying exact phosphorylation sites\",\n      \"pmids\": [\"9162092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MLK2 activates both MKK4 (SKK1) and MKK7 (SKK4) in transfection studies and in vitro, whereas MEKK1 activates MKK4 much more efficiently than MKK7 and barely activates MKK7. This differential activation suggests MEKK1 does not mediate cytokine (IL-1, TNF)-induced MKK7/JNK activation, while MLK2 can activate both arms.\",\n      \"method\": \"Cotransfection kinase assays, in vitro kinase assay with recombinant proteins\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution combined with cell-based assays, single lab\",\n      \"pmids\": [\"9639556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The activated MEKK1→SEK1/MKK4 pathway induces COX-2 expression and PGE2 production, functioning as an upstream kinase capable of activating both p38 MAPK and JNK/SAPK. A constitutively active SEK1-ED increased p38 and JNK phosphorylation and PGE2/COX-2, while a dominant-negative SEK1-AL decreased these outputs.\",\n      \"method\": \"Overexpression of constitutively active and dominant-negative constructs, kinase activity assays, pharmacologic p38 inhibitor\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain/loss-of-function with defined molecular readouts, single lab, two orthogonal approaches\",\n      \"pmids\": [\"9582321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"SEK1/MKK4-deficient T cells show decreased proliferation and IL-2 production after CD28 costimulation and PMA/Ca2+ ionophore activation, establishing MKK4 as a required effector of CD28 signaling to IL-2 production. JNK activation in response to PMA/Ca2+ ionophore was absent in KO thymocytes but present in peripheral T cells, indicating developmentally regulated signaling.\",\n      \"method\": \"RAG2-/-chimeric mice with SEK1-/- cells, genetic KO, functional proliferation and cytokine assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO in primary cells with defined functional readouts, developmental context established\",\n      \"pmids\": [\"9294148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"MEKK1 phosphorylates and activates MKK4 (and MKK1), and MEKK1's own ubiquitylation (mediated by its PHD/E3 ligase domain, requiring kinase activity and Cys441) inhibits its ability to phosphorylate MKK4, thereby suppressing ERK1/2 and JNK activation. Mutation C441A prevents ubiquitylation and preserves MEKK1→MKK4 phosphorylation.\",\n      \"method\": \"In vitro kinase assay, ubiquitylation assay, site-directed mutagenesis (C441A PHD domain)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis, functional epistasis established\",\n      \"pmids\": [\"12456688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MKK4/SEK1 undergoes ubiquitination and proteasomal degradation following cellular stress (sorbitol). The HECT-domain E3 ubiquitin ligase Itch binds MKK4, ubiquitinates lysines 140 and 143, and promotes MKK4 degradation through a JNK-dependent feedback loop (JNK kinase activity is required for MKK4 ubiquitination).\",\n      \"method\": \"Ubiquitination assays, co-immunoprecipitation, proteasome inhibitor treatment, site-directed mutagenesis of ubiquitin acceptor lysines\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical ubiquitination assay with site identification by mutagenesis, co-IP, and functional readout, single lab\",\n      \"pmids\": [\"19737936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nonvisual arrestins (arrestin-2 and arrestin-3) directly bind both MKK4 and JNK3α2 and act as scaffolds facilitating MKK4-mediated phosphorylation of JNK3α2. Reconstitution with purified proteins showed bell-shaped concentration dependence of JNK3α2 phosphorylation and JNK activity at low vs. high arrestin-3 concentration, consistent with true scaffold behavior. Arrestin-3 has higher affinity for both kinases than arrestin-2.\",\n      \"method\": \"In vitro reconstitution with purified proteins, direct binding assays, kinase activity assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution from purified components with functional readout and dose-response characterization\",\n      \"pmids\": [\"22047447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In fibroblast-like synoviocytes from rheumatoid arthritis tissue, MKK4 and MKK7 co-immunoprecipitate with JNK, and MKK4 co-precipitates with MKK7, forming a stable ternary complex. This complex localizes to the cytoplasm by confocal microscopy, with JNK translocating to the nucleus after IL-1 stimulation. The complex phosphorylates c-Jun upon IL-1 stimulation.\",\n      \"method\": \"Co-immunoprecipitation, confocal microscopy, in vitro kinase assay of immunoprecipitated complex\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and functional activity from precipitated complex with localization data, single lab\",\n      \"pmids\": [\"13130464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"LRRK2 (Parkinson disease-associated kinase) phosphorylates MKK4 in vitro, exhibiting MAPKKK-like activity toward MKK4 and MKK7 as well as MKK3 and MKK6. The pathogenic G2019S and I2020T mutations show increased phosphotransferase activity toward MKK4.\",\n      \"method\": \"In vitro kinase assay with recombinant proteins, disease mutant comparison\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro kinase assay, single lab, no cellular validation of specific MKK4 site\",\n      \"pmids\": [\"19302196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"G2019S-LRRK2 phosphorylates MKK4 at Ser257 with augmented kinase activity in HEK293 cells, and phospho-MKK4(Ser257) is elevated in the substantia nigra of G2019S-LRRK2 transgenic mice. This leads to increased phospho-JNK and phospho-c-Jun, upregulated Bim and FasL, and caspase activation, identifying the LRRK2→MKK4→JNK→c-Jun pathway as a mediator of dopaminergic neuron degeneration.\",\n      \"method\": \"Cell-based kinase assay (HEK293 cells), phosphospecific Western blotting in transgenic mice, epistasis via pathway component measurement\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell and in vivo validation with phosphospecific antibodies, two orthogonal systems, single lab\",\n      \"pmids\": [\"22539006\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Filamin A (actin-binding protein 280) binds to both MKK4 and MKK7, connecting them in close proximity. Filamin family members A, B, and C interact with MKK4; the MKK7-binding region on Filamin A is distinct from its MKK4-binding region. Filamin-A-deficient cells show reduced MKK7 activation and impaired synergistic stress-induced JNK activation, establishing Filamin A as a scaffold linking the two MKK upstream kinases.\",\n      \"method\": \"Co-immunoprecipitation, Filamin-A-deficient cell lines, deletion mutant mapping, confocal co-localization, kinase assays\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, deletion mutant mapping, KO cells with functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"20156194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cardiac-specific deletion of MKK4 in mice results in exacerbated pathological cardiac hypertrophy and cardiomyocyte apoptosis upon pressure overload or chronic beta-adrenergic stimulation, associated with upregulated NFAT transcriptional activity. Physiological hypertrophy induced by swimming exercise was unaffected. MKK4 expression was reduced in heart failure patients.\",\n      \"method\": \"Conditional cardiac KO (Cre-lox), pressure overload and pharmacologic stress models, NFAT reporter assay, histology\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with mechanistic readout (NFAT activation), multiple stress conditions, translational correlation\",\n      \"pmids\": [\"19265040\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MKK4 kinase activity is essential for metastasis suppression in ovarian cancer. Expression of MKK6 (a p38-specific activator) suppressed metastatic colonization similarly to MKK4, while MKK7 (JNK-specific) had no effect, placing the p38 pathway downstream of MKK4 as the key pathway for metastasis suppression.\",\n      \"method\": \"Kinase-inactive mutant expression, MKK6/MKK7 substitution, in vivo SCID mouse metastasis model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — kinase-dead mutant, pathway-specific substitution, in vivo readout, mechanistic epistasis established\",\n      \"pmids\": [\"16489030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In prostate cancer, MKK4 and MKK7 kinase activities are active in the lung (secondary site) but not in the primary tumor, providing a biochemical basis for context-dependent metastasis suppression. MKK7 expression suppresses overt metastases (via JNK), whereas MKK6 had no effect in this model, indicating MKK4 suppresses prostate metastasis through JNK rather than p38.\",\n      \"method\": \"In vivo AT6.1 spontaneous metastasis model, MKK7/MKK6 expression constructs, phospho-specific Western blotting in primary vs. secondary site tissue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo model with tissue-level biochemical analysis, pathway-specific kinase substitution, single lab\",\n      \"pmids\": [\"16322247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"POSH scaffold protein co-immunoprecipitates with MLK3, MKK4, and phospho-JNK in the rat hippocampus following cerebral ischemia; interactions are enhanced during reperfusion. Intracerebroventricular POSH antisense oligodeoxynucleotides reduced POSH protein, decreased its interaction with MKK4 and phospho-JNKs, attenuated MLK3-MKK4-JNK activation, and increased neuronal survival.\",\n      \"method\": \"Co-immunoprecipitation from brain tissue, antisense knockdown, immunohistochemistry, histology (neuronal density)\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP from native tissue with functional antisense KD and neuronal survival readout, single lab\",\n      \"pmids\": [\"16248889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"MKK4 (Ser80) is phosphorylated by the PI3K/Akt pathway in ovarian cells in response to EGF and TGF-β, and this inactivating phosphorylation is blocked 50-60% by the PI3K/Akt inhibitor wortmannin. The inactivated pSer80 form constitutes 62% of phosphorylated MKK4 in ovarian tumors, providing a mechanism for MKK4 functional inactivation without gene mutation.\",\n      \"method\": \"Western blotting with phosphospecific antibodies, pharmacologic inhibition (wortmannin), growth factor stimulation experiments\",\n      \"journal\": \"Gynecologic oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — phosphospecific antibody readout with pharmacologic inhibition, single lab, no direct kinase-substrate assay\",\n      \"pmids\": [\"17276500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Map2k4 functions as a tumor suppressor in lung adenocarcinoma; conditional bronchial epithelial inactivation in Kras/Tp53-mutant mice accelerated lung neoplasia. MKK4 deficiency increased PPARγ2 expression through noncanonical substrates, and PPARγ2 enhanced tumor cell invasion. Eight of 11 cancer-associated MKK4 mutations reduced protein stability or impaired kinase activity.\",\n      \"method\": \"Conditional KO in Kras/Tp53 mouse model, biochemical characterization of cancer-associated mutants, PPARγ2 epistasis via knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo conditional KO, kinase activity of tumor-associated mutants, and mechanistic substrate identification via epistasis\",\n      \"pmids\": [\"21896780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"G-protein βγ subunit (Gβγ) activates MKK4 (6-fold) more potently than MKK7 (2-fold), and MKK4 activation by Gβγ is blocked by dominant-negative Rho, Cdc42, and specific tyrosine kinase inhibitors PP2/PP1, while MKK7 activation is blocked by dominant-negative Rac. This demonstrates that Gβγ preferentially signals to JNK through MKK4 via Rho/Cdc42 and tyrosine kinases.\",\n      \"method\": \"Cotransfection with dominant-negative Rho GTPases, pharmacologic kinase inhibitors, kinase assays in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with multiple dominant-negative constructs and pharmacologic inhibitors, single lab\",\n      \"pmids\": [\"9890951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Delphinidin directly binds MAPKK4 (MKK4) and PI3K in an ATP-competitive manner, as demonstrated by pull-down with delphinidin-Sepharose beads, inhibiting their kinase activities and suppressing UVB-induced COX-2 expression in epidermal cells and mouse skin.\",\n      \"method\": \"Delphinidin-Sepharose pulldown assay (direct binding), in vitro kinase inhibition assay, in vivo mouse skin model\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct affinity pulldown with functional kinase inhibition readout, in vivo validation, single lab\",\n      \"pmids\": [\"19776176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In ESC differentiation, MKK4 is required for p38 activation; Mkk4−/− ESCs display diminished phospho-ATF2 and MEF2C expression, resulting in impaired MHC induction and defective cardiomyocyte differentiation. Exogenous MKK4 expression partially restored cardiomyocyte differentiation. MKK7, by contrast, reduces p38 activation, and Mkk7−/− ESCs have elevated MKK4 and p38 phosphorylation and enhanced cardiomyocyte formation.\",\n      \"method\": \"Gene KO ESC lines, differentiation assays, phospho-specific Western blot, MKK4 rescue transfection\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary KO lines with rescue experiment, multiple downstream signaling readouts, functional differentiation phenotype\",\n      \"pmids\": [\"22130668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PKC phosphorylation of JNK augments (but is not sufficient for) JNK activation by MKK4 or MKK7. In vitro kinase assays show that PKC phosphorylation of JNK must precede phosphorylation by MKK4/7 to enhance JNK activity. Inhibiting PKC phosphorylation of JNK affects both early and late phases of UV-induced JNK activation and reduces JNK-mediated apoptosis.\",\n      \"method\": \"In vitro kinase assay, sequential phosphorylation order experiments, pharmacologic PKC inhibition, apoptosis assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with order-of-addition experiment, single lab, limited cellular validation\",\n      \"pmids\": [\"18182317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Different scaffold proteins differentially utilize MKK4 and MKK7 for JNK activation: LMP-1-induced JNK activation depends primarily on MKK4, Axin depends mainly on MKK7, and Dvl depends approximately equally on both. This was demonstrated using MKK4−/− and MKK4−/−/7−/− murine embryonic fibroblasts.\",\n      \"method\": \"Genetic KO MEFs (MKK4−/−, MKK4−/−/7−/−), scaffold protein overexpression, JNK activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with scaffold-specific epistasis, multiple scaffolds tested, single lab\",\n      \"pmids\": [\"17187786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Knockdown of Sec8 enhances binding of JIP4 (JNK-interacting protein 4) to MKK4 and decreases the phosphorylation of MKK4, JNK, and p38, suggesting Sec8 regulates MKK4-JNK signaling by modulating JIP4-MKK4 scaffold interactions.\",\n      \"method\": \"Sec8 siRNA knockdown, co-immunoprecipitation (JIP4-MKK4 binding), phospho-specific Western blot\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP with indirect KD approach, single lab, no direct binding/kinase assay for MKK4\",\n      \"pmids\": [\"25244576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MAP3K1 and MAP2K4 loss-of-function mutations confer sensitivity to MEK inhibition by disabling a JNK-JUN feedback loop that normally restores MAPK pathway activity upon MEK inhibition. MEK inhibition activates JNK-JUN signaling through suppression of DUSP4, and cancers lacking MAP2K4 fail to activate this feedback, disabling compensatory pathway re-activation.\",\n      \"method\": \"Loss-of-function mutation analysis in cancer cell lines and PDX models, DUSP4 modulation, JNK-JUN pathway measurements, 168-tumor PDX panel drug response\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in multiple cancer models and large PDX panel, mechanistic pathway dissection, single study\",\n      \"pmids\": [\"29795445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"First-in-class small molecule inhibitors of MKK4 (MKK4i) were developed via structure-based design (NMR spectroscopy characterization). MKK4i increased liver regeneration upon hepatectomy in murine and porcine models, allowed pig survival in an 85% hepatectomy model, and showed antisteatotic and antifibrotic effects in liver disease models. A phase I clinical trial with candidate HRX215 showed acceptable safety and pharmacokinetics.\",\n      \"method\": \"Structure-based drug design, NMR spectroscopy characterization, in vivo hepatectomy models (mouse, pig), liver disease mouse models, phase I clinical trial\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structure-based development with NMR validation, multiple in vivo models including large animal, and first-in-human trial\",\n      \"pmids\": [\"38490194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A dual covalent MKK4/7 inhibitor (BSJ-04-122) was developed that targets a conserved cysteine before the DFG motif in both kinases. It exhibits potent cellular target engagement, downstream JNK pathway inhibition, and enhanced antiproliferative activity in triple-negative breast cancer cells when combined with a JNK inhibitor.\",\n      \"method\": \"Covalent inhibitor design, proteomics-based target engagement (mass spectrometry), kinase selectivity profiling, cell viability assays\",\n      \"journal\": \"Cell chemical biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — covalent active-site targeting with MS validation and functional cellular readout, single lab\",\n      \"pmids\": [\"32916088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In the Drosophila JNK pathway, Mkk4 plays a non-redundant role as a MAPKK acting in parallel to Hemipterous/Mkk7 in dTAK1-mediated JNK activation upon Eiger (TNF) and Imd pathway stimulation. Drosophila Mkk4 is dispensable for normal development but required (with Hep/Mkk7) for full JNK activation in the immune context.\",\n      \"method\": \"Dominant suppressor screen, allelic series genetic analysis, biochemical assays in Drosophila cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in Drosophila (ortholog system) with biochemical validation, multiple alleles\",\n      \"pmids\": [\"19888449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In retinal ganglion cells, deficiency of Mkk4 or Mkk7 individually reduced JNK signaling after axonal injury (optic nerve crush) and each increased RGC survival. Combined deficiency of both Mkk4 and Mkk7 caused failure of optic nerve formation, irregular axonal trajectories, disrupted retinal lamination, and dendritic fasciculation, demonstrating redundant developmental roles and individual contributions to injury-induced apoptosis.\",\n      \"method\": \"Conditional retina-specific KO, optic nerve crush model, immunohistochemistry, RGC counting\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — single and double conditional KO with defined developmental and injury phenotypes, quantitative RGC survival data\",\n      \"pmids\": [\"30367030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Targeted deletion of MKK4 abrogates TNF-induced NF-κB activation (IKK activation, IκBα phosphorylation/degradation, p65 nuclear translocation) and downregulates NF-κB-regulated anti-apoptotic gene products (survivin, IAP1, XIAP, Bcl-2, Bcl-xL, cFLIP), enhancing TNF-induced apoptosis in MKK4-KO fibroblasts.\",\n      \"method\": \"MKK4 gene-deleted fibroblasts from KO mice, NF-κB DNA binding assays, NF-κB reporter assay, Western blot for pathway components\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with multiple NF-κB pathway readouts and anti-apoptotic gene product measurements\",\n      \"pmids\": [\"17641059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MAP2K4 interacts with Vimentin (co-immunoprecipitation) and activates the PI3K/AKT signaling pathway in breast cancer cells, promoting proliferation, migration, and invasion through downstream c-JUN activation, G1/S cell cycle progression, and EMT. MAP2K4 knockdown reversed these effects.\",\n      \"method\": \"Co-immunoprecipitation (MAP2K4-Vimentin), KD/OE in breast cancer cell lines, in vivo xenograft, phospho-PI3K/AKT Western blot\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single co-IP, single lab, no mechanistic dissection of direct phosphorylation between MAP2K4 and PI3K/AKT\",\n      \"pmids\": [\"31761784\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAP2K4 (MKK4/SEK1/JNKK1) is a dual-specificity MAPK kinase that preferentially phosphorylates the activating tyrosine (Tyr-185) of JNK and acts synergistically with MKK7 (which targets Thr-183) to fully activate JNK; it can also activate p38 MAPK. MKK4 is activated by upstream MAPKKKs including MEKK1, MEKK2, MEKK3, MLK2, ASK1, and LRRK2 (Parkinson-associated) through phosphorylation of Ser221/Thr225. Its specificity is conferred by an N-terminal extension that organizes sequential interactions within the MEKK1→MKK4→JNK module, and it is assembled into signalosomes by scaffold proteins (arrestin-3, POSH, Filamin A). MKK4 activity is negatively regulated by Itch-mediated ubiquitination at Lys140/143 (a JNK-dependent feedback) and by PI3K/Akt-driven phosphorylation at the inactivating Ser80 site. In vivo, MKK4 is essential for embryonic viability, regulates CD28-driven IL-2 production in T cells, NF-κB activation, cardiomyocyte stress responses (via NFAT signaling), retinal ganglion cell survival, and liver regeneration; small-molecule MKK4 inhibitors that enhance liver regeneration have entered phase I clinical trials.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAP2K4 (MKK4/SEK1/JNKK1) is a dual-specificity MAP kinase kinase that operates at the core of stress-activated MAPK signaling, transducing diverse upstream inputs into JNK and p38 activation [#0]. It directly activates JNK in vivo, and its loss blocks JNK activation by MEKK1, anisomycin, and heat shock, abolishes AP-1 transcriptional activity, and causes embryonic lethality [#0]. MKK4 shows a striking substrate preference for the activating tyrosine (Tyr-185) of JNK, complementing MKK7's threonine specificity so that the two kinases act synergistically for full JNK activation; this tyrosine-directed preference extends to p38 family substrates [#2]. Specificity within the cascade is achieved through MKK4's N-terminal extension, which organizes sequential MEKK1\\u2192MKK4\\u2192JNK interactions, with MEKK1 and JNK competing for binding [#1]. MKK4 is activated by phosphorylation at Ser221/Thr225 by multiple MAPKKKs including MEKK2, MEKK3, MLK2, MEKK1, and the Parkinson-associated kinase LRRK2 [#3, #4, #11]; the LRRK2\\u2192MKK4(Ser257)\\u2192JNK\\u2192c-Jun axis drives dopaminergic neuron degeneration [#12]. Pathway assembly is governed by scaffold proteins\\u2014nonvisual arrestins bridge MKK4 and JNK3 [#9], and Filamin A links MKK4 to MKK7 [#13]\\u2014while MKK4 activity is negatively regulated by Itch-mediated ubiquitination at Lys140/143 in a JNK-dependent feedback loop [#8] and by inactivating PI3K/Akt-driven phosphorylation at Ser80 [#18]. Physiologically, MKK4 is required for CD28-driven IL-2 production in T cells [#6], TNF-induced NF-\\u03baB activation and survival gene expression [#31], cardiomyocyte stress responses through NFAT [#14], retinal ganglion cell survival after injury [#30], and acts as a tumor suppressor in lung and metastatic cancers [#15, #19]; structure-guided MKK4 inhibitors enhance liver regeneration and have entered phase I trials [#27].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established MKK4 as a genuine in vivo activator of JNK rather than an in vitro curiosity, defining its essential role in stress-induced AP-1 signaling and development.\",\n      \"evidence\": \"Targeted gene disruption with complementation rescue and AP-1 reporter assays; KO mice lethal before E14\",\n      \"pmids\": [\"9096336\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve relative contributions of JNK vs p38 downstream\", \"Embryonic lethality limited adult tissue analysis\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identified the exact activating phosphorylation sites and multiple MAPKKK inputs, showing MKK4 integrates signals from several upstream kinases.\",\n      \"evidence\": \"In vitro kinase assays with Ser221/Thr225 mutagenesis, cotransfection of MEKK2/MEKK3 in COS-7 cells\",\n      \"pmids\": [\"9162092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish which MAPKKK dominates in specific physiological stimuli\", \"Specificity of MEKK2/3 vs MKK3 not fully mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined how MKK4 organizes a discrete kinase module, revealing sequential and competitive interactions that confer stimulus-specific signaling.\",\n      \"evidence\": \"Co-IP, dominant-negative mutants, and N-terminal extension mutagenesis dissecting TNF- vs stress-induced JNK activation\",\n      \"pmids\": [\"9808624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of competitive binding not solved\", \"Stimulus specificity mechanism incompletely defined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Established differential MAPKKK preferences (MLK2 activates both MKK4 and MKK7; MEKK1 favors MKK4), explaining branch-specific upstream control of the JNK pathway.\",\n      \"evidence\": \"Cotransfection and in vitro kinase assays with recombinant proteins\",\n      \"pmids\": [\"9639556\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map endogenous cytokine-specific MAPKKK usage\", \"p38 branch contribution not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved the dual-residue logic of JNK activation, showing MKK4 preferentially phosphorylates Tyr-185 and acts synergistically with MKK7's Thr-183 targeting.\",\n      \"evidence\": \"In vitro kinase assays with phosphosite mutants and phosphoamino acid analysis across JNK isoforms\",\n      \"pmids\": [\"11062067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro preference may not reflect all cellular contexts\", \"p38 phosphosite preference less quantified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Linked MKK4 to a defined immune output, demonstrating it is required for CD28-driven T cell IL-2 production and revealing developmentally regulated JNK signaling.\",\n      \"evidence\": \"RAG2-/- chimeras with SEK1-/- cells, proliferation and cytokine assays\",\n      \"pmids\": [\"9294148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of developmental difference between thymocytes and peripheral T cells unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Connected MKK4 to inflammatory gene output by placing the MEKK1\\u2192SEK1 pathway upstream of both p38 and JNK driving COX-2/PGE2.\",\n      \"evidence\": \"Constitutively active and dominant-negative SEK1 constructs with kinase and prostaglandin readouts\",\n      \"pmids\": [\"9582321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression-based; endogenous contribution not measured\", \"Direct vs indirect COX-2 induction not separated\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined an upstream GPCR-linked route, showing G\\u03b2\\u03b3 preferentially signals to JNK through MKK4 via Rho/Cdc42 and tyrosine kinases.\",\n      \"evidence\": \"Cotransfection with dominant-negative Rho GTPases and pharmacologic inhibitors in HEK293\",\n      \"pmids\": [\"9890951\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intermediate MAPKKK not identified\", \"Pharmacologic inhibitor specificity caveats\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Revealed an upstream negative-feedback layer where MEKK1 autoubiquitylation limits its own ability to phosphorylate MKK4.\",\n      \"evidence\": \"In vitro kinase and ubiquitylation assays with PHD domain C441A mutant\",\n      \"pmids\": [\"12456688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular relevance and kinetics of feedback not fully quantified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated MKK4, MKK7, and JNK form a stable cytoplasmic ternary complex in disease tissue that phosphorylates c-Jun upon IL-1 stimulation.\",\n      \"evidence\": \"Reciprocal co-IP, confocal microscopy, and in vitro kinase assays in rheumatoid synoviocytes\",\n      \"pmids\": [\"13130464\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Scaffold organizing the complex not identified here\", \"Stoichiometry undefined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showed MKK4 suppresses metastasis in a context-dependent manner, acting through JNK in prostate cancer with site-specific kinase activation.\",\n      \"evidence\": \"In vivo AT6.1 metastasis model with MKK6/MKK7 substitution and phospho-Western in primary vs secondary tissue\",\n      \"pmids\": [\"16322247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of site-restricted activation unknown\", \"Contrasts with p38-dependent suppression in ovarian cancer\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Established that the downstream pathway mediating MKK4 metastasis suppression is tissue-dependent (p38 in ovarian cancer), using pathway-specific kinase substitution.\",\n      \"evidence\": \"Kinase-inactive MKK4 and MKK6/MKK7 substitution in SCID mouse ovarian metastasis model\",\n      \"pmids\": [\"16489030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of p38 vs JNK pathway choice unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated scaffold proteins differentially channel signals through MKK4 vs MKK7, defining branch selection at the scaffold level.\",\n      \"evidence\": \"JNK activity assays in MKK4-/- and MKK4-/-/7-/- MEFs with LMP-1, Axin, and Dvl\",\n      \"pmids\": [\"17187786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of scaffold-MKK preference not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Connected MKK4 to canonical NF-\\u03baB survival signaling, showing its loss abrogates TNF-induced NF-\\u03baB activation and sensitizes cells to apoptosis.\",\n      \"evidence\": \"MKK4-deleted fibroblasts with NF-\\u03baB DNA binding, reporter, and anti-apoptotic gene readouts\",\n      \"pmids\": [\"17641059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link between MKK4 and IKK not established\", \"Crosstalk with JNK arm not dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Revealed a priming layer where PKC phosphorylation of JNK must precede MKK4/7 action to augment JNK activity.\",\n      \"evidence\": \"In vitro sequential phosphorylation assays with PKC inhibition and apoptosis readout\",\n      \"pmids\": [\"18182317\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular validation limited\", \"PKC isoform and JNK site not specified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified Itch-mediated ubiquitination at Lys140/143 as a JNK-dependent negative feedback controlling MKK4 stability.\",\n      \"evidence\": \"Ubiquitination assays, co-IP, proteasome inhibition, and acceptor-lysine mutagenesis after sorbitol stress\",\n      \"pmids\": [\"19737936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological stimuli triggering this feedback beyond sorbitol unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined an inactivating phosphorylation mechanism (Ser80 via PI3K/Akt) that silences MKK4 in tumors without gene mutation.\",\n      \"evidence\": \"Phosphospecific Western blotting with wortmannin and growth factor stimulation in ovarian cells\",\n      \"pmids\": [\"17276500\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct kinase-substrate relationship not demonstrated\", \"Identity of the Ser80 kinase not confirmed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected MKK4 to neurodegeneration by identifying LRRK2 as a MAPKKK acting on MKK4, with pathogenic mutants showing enhanced activity.\",\n      \"evidence\": \"In vitro kinase assays with recombinant LRRK2 and G2019S/I2020T mutant comparison\",\n      \"pmids\": [\"19302196\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No cellular validation of the specific MKK4 site in this study\", \"Selectivity among MKKs not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established a scaffold-based assembly of the MLK3-MKK4-JNK module in ischemic neurons, with POSH disruption promoting survival.\",\n      \"evidence\": \"Co-IP from rat hippocampus and antisense knockdown after cerebral ischemia\",\n      \"pmids\": [\"16248889\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MKK4-POSH binding interface not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined a cardioprotective role: cardiac MKK4 deletion exacerbates pathological hypertrophy and apoptosis via elevated NFAT activity.\",\n      \"evidence\": \"Conditional cardiac KO under pressure overload and beta-adrenergic stress with NFAT reporter and patient correlation\",\n      \"pmids\": [\"19265040\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between MKK4 and NFAT suppression not fully defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified Filamin A as a scaffold physically linking MKK4 and MKK7 to enable their synergistic stress-induced JNK activation.\",\n      \"evidence\": \"Reciprocal co-IP, deletion mapping, Filamin-A-deficient cells, and kinase assays\",\n      \"pmids\": [\"20156194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Filamin A also organizes JNK in the complex not shown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstituted arrestin-3 as a bona fide scaffold for MKK4-mediated JNK3 phosphorylation, demonstrating classic scaffold concentration dependence.\",\n      \"evidence\": \"In vitro reconstitution from purified proteins with binding and dose-response kinase assays\",\n      \"pmids\": [\"22047447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of arrestin scaffolding for MKK4 not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established MKK4 as a lung adenocarcinoma tumor suppressor acting through noncanonical substrates (PPAR\\u03b32), with cancer mutations impairing stability or kinase activity.\",\n      \"evidence\": \"Conditional KO in Kras/Tp53 mice, biochemical mutant characterization, and PPAR\\u03b32 epistasis\",\n      \"pmids\": [\"21896780\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct MKK4 substrate driving PPAR\\u03b32 regulation not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed MKK4 is required for p38 activation during cardiomyocyte differentiation, with MKK4 and MKK7 exerting opposing effects on p38 output.\",\n      \"evidence\": \"Mkk4-/- and Mkk7-/- ESC differentiation assays with phospho-ATF2/MEF2C readouts and MKK4 rescue\",\n      \"pmids\": [\"22130668\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which MKK7 antagonizes p38 not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Validated the LRRK2\\u2192MKK4(Ser257)\\u2192JNK\\u2192c-Jun axis as a driver of dopaminergic neuron degeneration in cells and transgenic mice.\",\n      \"evidence\": \"Cell-based kinase assays in HEK293, phosphospecific Western in G2019S-LRRK2 transgenic substantia nigra, pathway component measurement\",\n      \"pmids\": [\"22539006\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal requirement of MKK4 for neurodegeneration not tested by MKK4 deletion\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Revealed MKK4 deficiency as a determinant of MEK inhibitor sensitivity by disabling a JNK-JUN feedback loop that normally restores MAPK activity.\",\n      \"evidence\": \"Loss-of-function analysis in cancer cell lines and a 168-tumor PDX panel with DUSP4 modulation\",\n      \"pmids\": [\"29795445\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MKK4 substrates in the feedback loop not enumerated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated individual and redundant roles of MKK4 and MKK7 in retinal ganglion cell survival and development through single and double KO.\",\n      \"evidence\": \"Conditional retina-specific KO with optic nerve crush and quantitative RGC survival counts\",\n      \"pmids\": [\"30367030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of developmental redundancy not dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Delivered a covalent MKK4/7 inhibitor targeting a conserved pre-DFG cysteine, enabling combinatorial pathway suppression in cancer cells.\",\n      \"evidence\": \"Covalent inhibitor design with MS-based target engagement and TNBC cell viability assays\",\n      \"pmids\": [\"32916088\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dual MKK4/7 inhibition complicates attribution to MKK4 alone\", \"In vivo efficacy not established here\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Translated MKK4 inhibition into a regenerative therapy, with structure-based MKK4 inhibitors enhancing liver regeneration and entering first-in-human testing.\",\n      \"evidence\": \"Structure-based design with NMR, mouse and pig hepatectomy models, liver disease models, and phase I trial of HRX215\",\n      \"pmids\": [\"38490194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term safety and efficacy from larger trials pending\", \"Tumor-suppressor role raises theoretical oncogenic risk not resolved here\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MKK4 selects between JNK and p38 outputs in different tissues, and how its substrate choice is reconciled with its dual tumor-suppressor and pro-survival roles, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model for tissue-specific JNK vs p38 channeling\", \"Noncanonical substrates largely uncharacterized\", \"Reconciliation of tumor suppression with regenerative inhibitor strategy incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 3, 9]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 9, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12, 30, 31]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [15, 19, 26]}\n    ],\n    \"complexes\": [\"MKK4-MKK7-JNK ternary complex\"],\n    \"partners\": [\"MAP3K1\", \"MAP2K7\", \"MAPK8\", \"ARRB2\", \"ARRB1\", \"FLNA\", \"ITCH\", \"LRRK2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}